Competitor Analysis c-Met/HGF Inhibitors

  • February 2010
  • -
  • La Merie Publishing

Product description

The Competitive Intelligence Report c-MET/HGF Inhibitors as of February 2010 provides a competitor analysis in the development pipeline of novel emerging inhibitors of c-MET receptor tyrosine kinase (RTK) and its ligand hepatocyte growth factor (HGF) or scatter factor (SF) for treatment of solid tumors. Most of the inhibitors are small molecules, but antibodies are a strongly emerging class of c-Met/HGF antagonists.

The c-MET signalling pathway consists of the mesenchymal epithelial transition factor (c-MET) transmembrane tyrosine kinase receptor and its ligand hepatocyte growth factor (HGF) or scatter factor (SF). Binding of HGF/SF to c-MET activates downstream signalling pathways such as Rho, focal adhesion kinase (FAK) and PI3K. These pathways regulate cancer cell growth, survival angiogenesis, invasion and metastasis. Thus, prevention of c-MET dependent neoplastic processes may provide a means for managing invasive tumors of high metastatic potential. In fact, c-MET/HGF has evolved as an attractive target for the pharmaceutical industry.

At present, at least 16 different molecules including four antibodies are in clinical development and quite a number of projects are in preclinical development. The majority of approaches are directed at inhibiting the c-MET receptor tyrosine kinsase (RTK) by small molecules. The first generation of c-MET RTK inhibitors are dual- or multi-targeting c-MET inhibitors. These multi-target c-MET inhibitors are most advanced in clinical development with two projects in phase III. The next wave of c-MET inhibitors typically are ATP-competitive potent and highly selective c-MET inhibitors with lead compounds in phase II.

The Competitor Analysis c-MET/HGF Inhibitors also provides the corporate R&D pipelines for c-MET/HGF Inhibitors. The report includes a compilation of current active projects in research and development of c-Met/HGF Inhibitors. Competitor projects are listed in a tabular format providing Information on:

* Drug Codes,
* Target / Mechanism of Action,
* Class of Compound,
* Company,
* Product category,
* Indication,
* R&D Stage and
* additional comments with a hyperlink leading to the source of information.


* Selective c-MET/HGF Inhibitors
* Dual- and Multi-Targeting c-MET/HGF Inhibitors
* C-Met/HGF Inhibitory Antibodies

Table Of Contents

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Proteomics Markets for Research and IVD Applications

Proteomics Markets for Research and IVD Applications

  • $ 4 200
  • Industry report
  • September 2014
  • by Kalorama Information

This Kalorama Information report defines markets and identifies trends for proteomics applications, both in their research use and in IVD. Proteomics is the study of proteins, including the study of the ...

Biologicals in Oncology Drug Pipeline Update 2014

Biologicals in Oncology Drug Pipeline Update 2014

  • $ 3 749
  • Industry report
  • July 2014
  • by Bioseeker

This drug pipeline update covers a wide array of biological drugs, such as: antibodies,proteins, peptides, DNA, RNA and cellular therapies. There are today 908 companies plus partners developing 1686 biological ...

Biologicals in Oncology: Drug Pathway Analyzer 2014

Biologicals in Oncology: Drug Pathway Analyzer 2014

  • $ 3 675
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 1421 biological drugs known to affect more than 266 specific intracellular signaling pathways for the treatment ...

5 Companies

Company Profiles

UCL Union

United Kingdom

Novartis Inc.


Linkedin Corp.

United States

Insmed Inc.

United States

Celgene Corp.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.